Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Schulz

Showing results (251-260 of 383) with videos related to

Pageof 39
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2015
Mapisal Versus Urea Cream as Prophylaxis for Capecitabine-Associated Hand-Foot Syndrome: A Randomized Phase III Trial of the AIO Quality of Life Working GroupRalf-Dieter Hofheinz, Deniz Gencer, Holger Schulz, et al.
Psycho-Oncology|July 14, 2020
Risk and associated factors of depression and anxiety in men with prostate cancer: Results from a German multicenter studyPeter Esser, Anja Mehnert-Theuerkauf, Michael Friedrich, et al.
BMC Palliative Care|May 6, 2022
Dying in hospital in Germany - optimising care in the dying phase: study protocol for a multi-centre bottom-up intervention on ward levelKerstin Kremeike, Anneke Ullrich, Holger Schulz, et al.
Age and Ageing|December 16, 2016
Common eye diseases in older adults of southern Germany: results from the KORA-Age studyPeter Reitmeir, Birgit Linkohr, Margit Heier, et al.
Free Radical Biology & Medicine|March 23, 2005
Oxidative stress and lipid mediators induced in alveolar macrophages by ultrafine particlesIngrid Beck-Speier, Niru Dayal, Erwin Karg, et al.
Blood|October 18, 2002
Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemiaHolger Schulz, Saskia Karina Klein, Ute Rehwald, et al.
International Journal of Cancer|February 9, 2023
First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Final results of the NEPTUN studyTobias Dechow, Jorge Riera-Knorrenschild, Björn Hackanson, et al.
The Journal of Clinical Psychiatry|April 12, 2012
Cost-effectiveness of 12-month therapeutic assertive community treatment as part of integrated care versus standard care in patients with schizophrenia treated with quetiapine immediate release (ACCESS trial)Anne Karow, Jens Reimer, Hans Helmut König, et al.
Particle and Fibre Toxicology|December 6, 2008
Exposure to ultrafine carbon particles at levels below detectable pulmonary inflammation affects cardiovascular performance in spontaneously hypertensive ratsSwapna Upadhyay, Tobias Stoeger, Volkar Harder, et al.
Respiratory Research|August 11, 2017
Transcriptomic analysis comparing mouse strains with extreme total lung capacities identifies novel candidate genes for pulmonary functionLeema George, Ankita Mitra, Tania A Thimraj, et al.
Pageof 39

Showing results (251-260 of 383) with videos related to

Sort By:
Pageof 39
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2015
Mapisal Versus Urea Cream as Prophylaxis for Capecitabine-Associated Hand-Foot Syndrome: A Randomized Phase III Trial of the AIO Quality of Life Working GroupRalf-Dieter Hofheinz, Deniz Gencer, Holger Schulz, et al.
Psycho-Oncology|July 14, 2020
Risk and associated factors of depression and anxiety in men with prostate cancer: Results from a German multicenter studyPeter Esser, Anja Mehnert-Theuerkauf, Michael Friedrich, et al.
BMC Palliative Care|May 6, 2022
Dying in hospital in Germany - optimising care in the dying phase: study protocol for a multi-centre bottom-up intervention on ward levelKerstin Kremeike, Anneke Ullrich, Holger Schulz, et al.
Age and Ageing|December 16, 2016
Common eye diseases in older adults of southern Germany: results from the KORA-Age studyPeter Reitmeir, Birgit Linkohr, Margit Heier, et al.
Free Radical Biology & Medicine|March 23, 2005
Oxidative stress and lipid mediators induced in alveolar macrophages by ultrafine particlesIngrid Beck-Speier, Niru Dayal, Erwin Karg, et al.
Blood|October 18, 2002
Phase 2 study of a combined immunochemotherapy using rituximab and fludarabine in patients with chronic lymphocytic leukemiaHolger Schulz, Saskia Karina Klein, Ute Rehwald, et al.
International Journal of Cancer|February 9, 2023
First-line nab-paclitaxel plus carboplatin for patients with advanced non-small cell lung cancer: Final results of the NEPTUN studyTobias Dechow, Jorge Riera-Knorrenschild, Björn Hackanson, et al.
The Journal of Clinical Psychiatry|April 12, 2012
Cost-effectiveness of 12-month therapeutic assertive community treatment as part of integrated care versus standard care in patients with schizophrenia treated with quetiapine immediate release (ACCESS trial)Anne Karow, Jens Reimer, Hans Helmut König, et al.
Particle and Fibre Toxicology|December 6, 2008
Exposure to ultrafine carbon particles at levels below detectable pulmonary inflammation affects cardiovascular performance in spontaneously hypertensive ratsSwapna Upadhyay, Tobias Stoeger, Volkar Harder, et al.
Respiratory Research|August 11, 2017
Transcriptomic analysis comparing mouse strains with extreme total lung capacities identifies novel candidate genes for pulmonary functionLeema George, Ankita Mitra, Tania A Thimraj, et al.
Pageof 39